Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline
Clinical trial NCT00506415 · COMPLETED
Trial details
- NCT number
- NCT00506415
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Primary completion
- 2011-05-01
- Enrollment
- 1584
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.